Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.
Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.
复制标题
DOI:
--
复制
发表时间:
2005
期刊:
影响因子:
82.9
通讯作者:
D. Cai;M. Yuan;Daniel F Frantz;P. A. Meléndez;L. Hansen;Jongsoon Lee;S. Shoelson
中科院分区:
文献类型:
--
作者:
D. Cai;M. Yuan;Daniel F Frantz;P. A. Meléndez;L. Hansen;Jongsoon Lee;S. Shoelson
We show that NF-kappaB and transcriptional targets are activated in liver by obesity and high-fat diet (HFD). We have matched this state of chronic, subacute 'inflammation' by low-level activation of NF-kappaB in the liver of transgenic mice, designated LIKK, by selectively expressing constitutively active IKK-b in hepatocytes. These mice exhibit a type 2 diabetes phenotype, characterized by hyperglycemia, profound hepatic insulin resistance, and moderate systemic insulin resistance, including effects in muscle. The hepatic production of proinflammatory cytokines, including IL-6, IL-1beta and TNF-alpha, was increased in LIKK mice to a similar extent as induced by HFD in in wild-type mice. Parallel increases were observed in cytokine signaling in liver and mucscle of LIKK mice. Insulin resistance was improved by systemic neutralization of IL-6 or salicylate inhibition of IKK-beta. Hepatic expression of the IkappaBalpha superrepressor (LISR) reversed the phenotype of both LIKK mice and wild-type mice fed an HFD. These findings indicate that lipid accumulation in the liver leads to subacute hepatic 'inflammation' through NF-kappaB activation and downstream cytokine production. This causes insulin resistance both locally in liver and systemically.